Provided by Tiger Trade Technology Pte. Ltd.

Enanta Pharmaceuticals

13.33
-0.2700-1.99%
Post-market: 13.330.00000.00%16:32 EDT
Volume:286.52K
Turnover:3.82M
Market Cap:386.82M
PE:-5.69
High:13.60
Open:13.52
Low:13.12
Close:13.60
52wk High:17.15
52wk Low:7.05
Shares:29.02M
Float Shares:22.51M
Volume Ratio:1.06
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3416
EPS(LYR):-3.8381
ROE:-70.12%
ROA:-12.28%
PB:3.83
PE(LYR):-3.47

Loading ...

Enanta Pharmaceuticals Flags Ongoing Uncertainty as 2025 Risk Factors Continue to Shape 2026 Outlook

TIPRANKS
·
Aug 13

Atea Pharmaceuticals Q2 Loss Narrows as HCV Trial Expenses Decline

Reuters
·
Aug 13

TherapeuticsMD Q2 License Revenue Falls; Continues to Evaluate Strategic Alternatives

Reuters
·
Aug 12

H.C. Wainwright Sticks to Their Buy Rating for Enanta Pharmaceuticals (ENTA)

TIPRANKS
·
Aug 11

Canada's Medexus Q1 Revenue Beats on Grafapex Strength

Reuters
·
Aug 11

Enanta Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Enanta Fiscal Q3 2026 Earnings: Higher Royalty-Related Interest Expense Widens Net Loss

TradingKey
·
Aug 11

Enanta Pharmaceuticals Q3 Revenue USD 14.359 Million Vs. IBES Estimate USD 16.8 Million

Reuters
·
Aug 11

Enanta Pharmaceuticals Q3 Revenue Misses Estimates, Hurt by Lower Royalties

Reuters
·
Aug 11

Enanta Pharma Q3 EPS $(0.67) Misses $(0.54) Estimate, Sales $14.359M Miss $16.796M Estimate

Benzinga Earnings
·
Aug 11

Enanta FY26 Q3 Net Loss Widens to $19.5 Million; Revenue Falls to $14.4 Million

Reuters
·
Aug 11

Enanta Pharmaceuticals: on Track to Report Topline Data from Phase 1 Trial of Edp-978 in 4Q 2026

THOMSON REUTERS
·
Aug 11

Enanta Pharmaceuticals Q3 Operating Income USD -17.236 Million

THOMSON REUTERS
·
Aug 11

Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2026

THOMSON REUTERS
·
Aug 11

Enanta Pharmaceuticals Inc Expected to Post a Loss of 51 Cents a Share - Earnings Preview

Reuters
·
Aug 08

U.S. Earnings Preview: After Market Close Aug. 7

Dow Jones
·
Aug 08

Enanta Enters $75 Million At-the-Market Stock Offering Agreement

MT Newswires Live
·
Jul 03

Enanta Pharmaceuticals Establishes Flexible At-The-Market Offering

TIPRANKS
·
Jul 03

Enanta Plans up to $75 Million At-the-market Stock Offering Via Jefferies

Reuters
·
Jul 03

Enanta Pharmaceuticals - Enters Open Market Sale Agreement with Jefferies - SEC Filing

THOMSON REUTERS
·
Jul 03